Allergan, Inc. (NYSE:AGN)

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

With just over six weeks left in what has been a very volatile 2018, many investors are wondering which direction the market will take now that Democrats are taking over ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Stocks were indicated to open lower on Thursday morning, though the S&P 500 hit an all-time high earlier in the week. Earnings season is all but over now and was ...
Read Full Story »

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch. This should not be ...
Read Full Story »

Tesla, Schlumberger and 4 Others With Recent Golden Crosses or Death Crosses

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages. The golden cross typically is seen as a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Cheniere, Clean Energy, Facebook, Fiat Chrysler, Intel, NetApp and More

Stocks were looking for a very strong open on Thursday after the Independence Day holiday had U.S. markets closed on Wednesday. The prior trend of buying the dips has been ...
Read Full Story »

Merrill Lynch Issues Top 8 US Stock Ideas for Q3 2018

It's hard to believe the first half of 2018 already has ended. It's also hard to imagine that the Dow Jones industrials and S&P 500 have done very little in ...
Read Full Story »

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

While large cap pharmaceutical stocks have had a very solid year despite the rumbling by the administration over drug pricing, many smaller specialty pharmaceuticals have lagged. Despite that underperformance, some ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Alphabet, BP, Epizyme, FirstEnergy, First Solar, KeyCorp, Nvidia, Vale and More

Stocks had been selling off up until today, but the major equity indices were up after strong earnings from the Dow Jones industrials added support. Some investors have reconsidered what ...
Read Full Story »

Merrill Lynch Makes Surprising Technology Addition to US 1 List

With earnings reporting for the first quarter right around the corner, many of the top companies we follow on Wall Street are making some changes to the lists of their ...
Read Full Story »

Dermira, Allergan Plunge into Monday’s 52-Week Low Club

March 5, 2018: Here are four stocks trading with heavy volume among 58 equities making new 52-week lows in Monday's session. On the NYSE advancers led decliners by more than ...
Read Full Story »

10 Large Cap Stocks the Top Hedge Funds Are Buying Now

While chasing what portfolio managers own isn’t always the best idea, many people have made a lot of money by simply mimicking what legendary investors like Warren Buffett hold. With ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Allergan, Boston Scientific, eBay, FedEx, Gogo, LendingTree, Nokia, UPS, Vertex and More

The stock market has demonstrated that perhaps the return of volatility is real after Wednesday's big gains suddenly turned into a big loss in the final 30 minutes of trading. ...
Read Full Story »

Merrill Lynch Makes Big Changes to US 1 List Adding New Financial Stock

With fourth-quarter earnings reporting about over and spring right around the corner, many of the top firms we follow here at 24/7 Wall St. are making changes to the lists ...
Read Full Story »

Why Allergan Continues to Slide

When Allergan PLC (NYSE: AGN) reported its most recent quarterly results before the markets opened on Tuesday, the company said that it had $4.86 in earnings per share (EPS) on ...
Read Full Story »

20 More Biopharma Catalysts Coming in 2018

Over the course of 2017, biopharmaceutical companies more or less kept pace with the markets, ending up with a return just a little higher than the S&P 500. But going in ...
Read Full Story »